GENE ONLINE|News &
Opinion
Blog

Anxiety
Asia-Pacific AnxietyPhase 3 Trial
Vistagen’s Positive Phase 3 Results for Social Anxiety Treatment
2023-08-10
Interviews 2022 psychedelics
The Renaissance of Psychedelics Research: An Interview with the CEO of MindMed, Rob Barrow
2022-04-12
Innovation Marijuana
Marijuana for Medical Use Increases the Risk of Cannabis Use Disorder
2022-03-25
Special 2022 psychedelics
From Forbidden Drugs to Psychotropic Cures: A “Psychedelic Boom” Breaks New Ground in Treating Mental Illnesses
2022-03-08
Funding Digital HealthcareSeries C Funding
Mental Healthcare Startup Cerebral Valued at $4.8 Billion after $300 Million Softbank-led Series C
2021-12-10
Trials & Approvals Anxiety
FDA Approves New Drug for Specific Treatment of Postpartum Depression
2019-03-21
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
READ MORE
EVENT
2023-10-04
BioFuture 2023
New York city,USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top